Mark Eccleston
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
- Hydrogels: synthesis, properties, applications
Papers in
-
- RNA Interference and Gene Delivery 9
- Biopolymer Synthesis and Applications 6
- Epigenetics and DNA Methylation 6
- Advanced biosensing and bioanalysis techniques 5
- RNA modifications and cancer 4
- Cancer-related gene regulation 2
-
- Hydrogels: synthesis, properties, applications 3
- Co-authors
- Nigel K.H. Slater (16 shared papers)Zhilian Yue (10 shared papers)Rongjun Chen (6 shared papers)Clemens F. Kaminski (5 shared papers)Sariah Khormaee (2 shared papers)Johannes Swartling (1 shared paper)Mariëlle Herzog (6 shared papers)Jake Micallef (3 shared papers)
- Journals
- Epigenomics (3 papers)Biomaterials (3 papers)Polymer (3 papers)Clinical Epigenetics (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Mark Eccleston
28 papers receiving 797 citations
Peers
Comparison fields: 5 of 78
- Biomaterials 208
- Molecular Medicine 62
- Pharmaceutical Science 50
- Surfaces, Coatings and Films 54
- Molecular Biology 482
Countries citing papers authored by Mark Eccleston
This map shows the geographic impact of Mark Eccleston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Eccleston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Eccleston more than expected).
Fields of papers citing papers by Mark Eccleston
This network shows the impact of papers produced by Mark Eccleston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Eccleston. The network helps show where Mark Eccleston may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Eccleston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 135 | |
| 2 | 2009 | 96 | |
| 3 | 2015 | 91 | |
| 4 | 2005 | 83 | |
| 5 | 2020 | 61 | |
| 6 | 2000 | 44 | |
| 7 | 2021 | 36 | |
| 8 | 2009 | 36 | |
| 9 | 2005 | 35 | |
| 10 | 1999 | 29 | |
| 11 | 2009 | 24 | |
| 12 | 2005 | 23 | |
| 13 | 2006 | 22 | |
| 14 | 2008 | 21 | |
| 15 | 2005 | 18 | |
| 16 | 2023 | 16 | |
| 17 | 2003 | 12 | |
| 18 | 2024 | 10 | |
| 19 | 2022 | 8 | |
| 20 | 2021 | 6 |
About Mark Eccleston
Mark Eccleston is a scholar working on Molecular Biology, Molecular Medicine, Transplantation, Biomaterials and Polymers and Plastics, having authored 28 papers that have together received 823 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Biopolymer Synthesis and Applications (6 papers), Epigenetics and DNA Methylation (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), RNA modifications and cancer (4 papers), Hydrogels: synthesis, properties, applications (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Biomaterials (208 citations), Molecular Medicine (62 citations), Pharmaceutical Science (50 citations), Surfaces, Coatings and Films (54 citations) and Molecular Biology (482 citations). Mark Eccleston has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Nigel K.H. Slater, Zhilian Yue, Rongjun Chen, Clemens F. Kaminski, Sariah Khormaee, Johannes Swartling, Mariëlle Herzog, Jake Micallef, Daniel Ansari and Roland E. Andersson. Their work appears in journals such as Epigenomics, Biomaterials, Polymer, Clinical Epigenetics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.